2024 |
eFFECTOR Therapeutics Inc
|
Independent Director |
- |
- |
2023 |
eFFECTOR Therapeutics Inc
|
Independent Director |
35.7 K |
- |
2023 |
eFFECTOR Therapeutics Inc - Warrants (26/08/2026)
|
Independent Director |
- |
- |
2023 |
Cymabay Therapeutics Inc
|
Independent Director |
- |
- |
2022 |
Cymabay Therapeutics Inc
|
Independent Director |
215.4 K |
2.7 % |
2022 |
Aptose Biosciences Inc
|
Independent Director |
84.4 K |
-61.5 % |
2022 |
Aptose Biosciences Inc
|
Independent Director |
- |
- |
2022 |
Phoenix Biotech Acquisition Corp - Ordinary Shares - Class A
|
Independent Director |
- |
- |
2021 |
Aptose Biosciences Inc
|
Independent Director |
219.0 K |
-64.7 % |
2021 |
Cymabay Therapeutics Inc
|
Independent Director |
209.7 K |
-5.8 % |
2020 |
Aptose Biosciences Inc
|
Independent Director |
620.9 K |
476.8 % |
2020 |
Cymabay Therapeutics Inc
|
Independent Director |
222.6 K |
12.2 % |
2019 |
Cymabay Therapeutics Inc
|
Independent Director |
198.5 K |
19.2 % |
2019 |
Aptose Biosciences Inc
|
Independent Director |
107.6 K |
8.4 % |
2018 |
Cymabay Therapeutics Inc
|
Independent Director |
166.5 K |
-5.4 % |
2018 |
Aptose Biosciences Inc
|
Independent Director |
99.3 K |
- |
2017 |
Cymabay Therapeutics Inc
|
Independent Director |
176.1 K |
5741.3 % |
2017 |
Aptose Biosciences Inc
|
Independent Director |
- |
- |
2016 |
Cymabay Therapeutics Inc
|
Independent Director |
3.0 K |
- |